North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group

 
back
8 Malignant disease and immunosuppression

For the most up to date list of agents funded by the Cancer Drugs Fund, please see Cancer Drug Fund List

The list should be read in conjunction with Appraisal and Funding of Cancer Drugs from July 2016 (including the new Cancer Drugs Fund).

08-03-04-02 Gonadorelin analogues

Triptorelin
Formulary

1st line

Decapeptyl SR (triptorelin acetate) 3mg vials - monthly
Decapeptyl SR (triptorelin) 11.25mg vials - three monthly
Decapeptyl SR (triptorelin embonate) 22.5mg vials - six monthly
Gonapeptyl Depot (triptorelin acetate) 3.75mg pre-filled syringes - monthly

 

In endometriosis do not use for longer than 6 months (do not repeat)

 

 

 


Amber View adult BNF  View SPC online  View childrens BNF
Degarelix acetate Firmagon®
Formulary

Firmagon (degarelix axetate) 80mg powder and solvent for solution for injection vials
Firmagon (degarelix axetate) 120mg powder and solvent for solution for injection vials

Restriction: In line with NICE Guidance only

 

Link  NICE TA404: Degarelix for treating advanced hormone-dependent prostate cancer
 

Amber View adult BNF  View SPC online  View childrens BNF
Goserelin acetate Zoladex®
Formulary

Zoladex (goserelin acetate) 3.6mg implant SafeSystem pre-filled syringes - monthly
Zoladex LA (goserelin acetate) 10.8mg implant SafeSystem pre-filled syringes -three monthly


Amber View adult BNF  View SPC online  View childrens BNF
Leuprorelin acetate
Formulary

Prostap SR DCS (leuprorelin acetate) 3.75mg powder and solvent for suspension for injection pre-filled syringes - monthly

Prostap 3 DCS (leuprorelin acetate) 11.25mg powder and solvent for suspension for injection pre-filled syringes - three monthly

 


Amber View adult BNF  View SPC online  View childrens BNF